Substâncias específicas de nova série de cosméticos para teste de contato: uma revisão narrativa
Specific substances in a new cosmetic patch test series: a narrative review
Rosana Zabulon Feijó Belluco Paulo Eduardo Silva Belluco; Jaime Alberto Guggiari; Martti Anton Antila; Jullia Eduarda Feijó Belluco; Fabíola Da Silva Maciel Azevedo
Resumo
As lesões de dermatite de contato constituem uma causa frequente de consulta na prática diária do alergista, entre elas, as induzidas por substâncias presentes em cosméticos. O diagnóstico adequado desses eczemas requer a realização de testes de contato por séries atualizadas com relevância clínica. No Brasil existe uma bateria de cosméticos antiga proveniente do período da composição da bateria padrão brasileira. Recentemente foi proposta uma nova série de cosméticos, com 20 elementos, seguindo-se o número específico de cada hapteno. Partindo-se desta sugestão, foi realizada busca nas bases de dados PubMed e ClinicalKey, considerando as publicações dos últimos 10 anos que conectavam os alérgenos no contexto da dermatite de contato. Neste cenário, esta revisão tem como objetivo explanar sobre os alérgenos selecionados envolvidos na dermatite de contato associada a cosméticos, destacando a importância científica atual destas substâncias e reafirmar a necessidade da criação de uma nova série específica.
Palavras-chave
Abstract
Contact dermatitis lesions are a frequent cause of consultation in the daily practice of allergists, particularly those induced by substances present in cosmetic products. Accurate diagnosis of these eczematous conditions requires patch testing using updated series with clinical relevance. In Brazil, the currently available cosmetic patch test series is outdated, originating from the period in which the Brazilian standard series was established. Recently, a new cosmetic series comprising 20 elements has been proposed, following the specific numbering of each hapten. Based on this proposal, a literature search was conducted in PubMed and ClinicalKey databases, focusing on publications from the past 10 years that addressed allergens in the context of contact dermatitis. Within this scenario, the present review aimed to discuss the selected allergens involved in cosmetic-related contact dermatitis, highlight their current scientific relevance, and reaffirm the need for the development of a new, specific cosmetic patch test series.
Keywords
Referências
1. Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução da Diretoria Colegiada – RDC N° 530, de 04 de Agosto de 2021. Dispõe sobre os requisitos técnicos para a regularização de produtos de higiene pessoal, cosméticos e perfumes [Internet]. Brasília: ANVISA; 2021.
2. Morin CB, Sasseville D. Expanding Patch Testing Beyond the Baseline Series: Usefulness of Customized Antimicrobials, Vehicles, and Cosmetics Series. Dermatitis. 2020;31(6):367-72. doi:10.1097/ DER.0000000000000674.
3. Belluco PES, Uber M, Silva F de P, Belluco JEF, Abagge KT, Belluco RZF, et al. New cosmetics patch test series : A proposal. Rev Alerg México. 2025;72(2):107-18. doi:10.29262/ram.v72i2.1437.
4. Karels S, Weber B, Neeley A. Demonstration of Cross-Reactivity Between trans-Anethole and Butylhydroxyanisole. Dermatitis. 2025 Jul-Aug;36(4):e397-e399. doi: 10.1089/derm.2024.0322.
5. Panico A, Serio F, Bagordo F, Grassi T, Idolo A, DE Giorgi M, et al. Skin safety and health prevention: an overview of chemicals in cosmetic products. J Prev Med Hyg. 2019;60(1):E50-E57. doi:10.15167/2421-4248/jpmh2019.60.1.1080.
6. Atwater AR, Liu B, Walsh R, Bembry R, Ward JM, Green CL. Supplemental Patch Testing Identifies Allergens Missed by Standard Screening Series. Dermatitis®. 2024;35(4):366-72. doi:10.1089/ derm.2023.0310.
7. Mertens S, Gilissen L, Goossens A. Allergic contact dermatitis caused by cocamide diethanolamine. Contact Dermatitis. 2016;75(1):20-4. doi:10.1111/cod.12580.
8. Navarro-Triviño FJ, Ruiz-Villaverde R. Genital allergic contact dermatitis caused by cocamide DEA. Contact Dermatitis. 2021;85(6):701-3. doi:10.1111/cod.13934.
9. Presley CL, Militello M, Barber C, Ladd R, Laughter M, Ferguson H, et al. The History of Surfactants and Review of Their Allergic and Irritant Properties. Dermatitis. 2021;32(5):289-97. doi:10.1097/ DER.0000000000000730.
10. Scheman A, Te R. Contact Allergy to Cocamide Diethanolamine and Cross-reactions. Dermatitis. 2018;29(2):91-2. doi:10.1097/ DER.0000000000000350.
11. Warshaw EM, Han J, Kullberg SA, DeKoven JG, Adler BL, Silverberg JI, et al. Patch Testing to Chlorhexidine Digluconate, 1% Aqueous: North American Contact Dermatitis Group Experience, 2015-2020. Dermatitis. 2023;34(6):501-8. doi:10.1089/derm.2023.0077.
12. Opstrup MS, Johansen JD, Zachariae C, Garvey LH. Contact allergy to chlorhexidine in a tertiary dermatology clinic in Denmark. Contact Dermatitis. 2016;74(1):29-36. doi:10.1111/cod.12487.
13. Schlarbaum JP, Hylwa SA. Allergic Contact Dermatitis to Operating Room Scrubs and Disinfectants. Dermatitis. 2019;30(6):363-70. doi:10.1097/DER.0000000000000525.
14. Calado R, Calvão da Silva J, Gomes T, Gonçalo M. Is there a place for chlorhexidine in the European baseline series? Contact Dermatitis. 2021;85(3):372-3. doi:10.1111/cod.13861.
15. Watts TJ, Li PH, Ue KL, Haque R. Chronic Allergic Contact Dermatitis Due to Chlorhexidine. J Allergy Clin Immunol Pract. 2018;6(1):254-5. doi:10.1016/j.jaip.2017.08.002.
16. Heurung AR, Raju SI, Warshaw EM. Benzophenones. Dermatitis. 2014;25(1):3-10. doi:10.1097/DER.0000000000000025.
17 Warshaw EM, Xiong M, Belsito DV, Adler BL, Atwater AR, DeKoven JG, et al. Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013–2020. Dermatitis. 2023;34(2):105-12. doi:10.1089/derm.2022.29013. ewa.
18 Hanson JL, Warshaw EM. Sensitivity to Multiple Benzophenone Sunscreen Agents. Dermatitis. 2015;26(4):192-4. doi:10.1097/ DER.0000000000000131.
19 Tsiogka A, Liopyris K, Gregoriou S. Allergic contact dermatitis associated with benzophenone sensitization after a recent black ink tattoo. Contact Dermatitis. 2022;86(6):549-51. doi:10.1111/ cod.14071.
20 Özkaya E, Pehlivan G, Babuna Kobaner G. Sorbitan sesquioleate: a rare contact allergen that is also an important indicator of allergic contact dermatitis from crossreacting compounds as well as for falsepositive fragrance allergy. Clin Exp Dermatol. 2022;47(7):1291-7. doi:10.1111/ced.15158.
21 Sukakul T, Bruze M, Mowitz M, Svedman C. Use of sorbitan sesquioleate in patch test preparations and patch testing with the substance—What do our results mean? Contact Dermatitis. 2023;88(2):134-8. doi:10.1111/cod.14239.
22 de Groot A, Gilissen L, Geier J, Orton D, Goossens A. Adding sorbitan sesquioleate to the European baseline series: Necessary, reasonable, or unavoidable? Contact Dermatitis. 2019;81(3):221-5. doi:10.1111/cod.13332.
23 Yokoi A, Suzuki K, Takahashi M, Yagami A, Matsunaga K. Case of allergic contact dermatitis caused by sorbitan derivatives included in an over‐the‐counter topical medicament. J Dermatol. 2017;44(6):e113-e114. doi:10.1111/1346-8138.13731.
24 Tripp M, Ribeiro M, Kmiecik S, Go R. A "Rash" Decision in Anesthetic Management: Benzyl Alcohol Allergy in the Perioperative Period. Case Rep Anesthesiol. 2021 Jun 24;2021:8859823. doi: 10.1155/2021/8859823.
25 Geier J, Ballmer-Weber B, Buhl T, Rieker-Schwienbacher J, Mahler V, Dickel H, et al. Is benzyl alcohol a significant contact sensitizer? J Eur Acad Dermatology Venereol. 2022;36(6):866-72.
26 Kubin ME, Riekki R. Benzyl alcohol allergy mimicking corticosteroid allergy. Contact Dermatitis. 2016;75(1):58-9. doi:10.1111/ cod.12562.
27 Xiong M, Peterson MY, Hylwa S. Allergic contact dermatitis from benzyl alcohol in hydrocortisone cream. Contact Dermatitis. 2022;86(5):424-5. doi:10.1111/cod.14042.
28 Atwater AR, Petty AJ, Liu B, Green CL, Silverberg JI, DeKoven JG, et al. Contact dermatitis associated with preservatives: Retrospective analysis of North American Contact Dermatitis Group data, 1994 through 2016. J Am Acad Dermatol. 2021;84(4):965-76. doi:10.1016/j.jaad.2020.07.059.
29 Beene KM, Scheman A, Severson D, Reeder MJ. Prevalence of Preservatives Across All Product Types in the Contact Allergen Management Program. Dermatitis. 2017;28(1):81-7. doi:10.1097/ DER.0000000000000259.
30 Väänänen A, Hannuksela M. Softisan – a new vehicle for patch testing. Contact Dermatitis. 1986;14(4):215-6. doi:10.1111/j.1600- 0536.1986.tb01227.x.
31 Sherson DL, Jacobsen IB, Thomsen GF. The antioxidant, tertbutylhydroquinone: a new cause of asthma. Occup Med (Chic Ill). 2023;73(2):109-11. doi:10.1093/occmed/kqac093.
32 Seiller H, Kurihara F, Chasset F, Soria A, Barbaud A. Tert ‐butylhydroquinone is a marker for sensitivity to Nigella sativa oil allergy: Five new cases. Contact Dermatitis. 2021;84(6):447-9. doi:10.1111/cod.13750.
33 Kurihara F, Soria A, Lepoittevin J, Chasset F, Barbaud A, Pecquet C. Thymoquinone as a causative allergen in Nigella sativa oil contact dermatitis with cross-reactivity to tert-butylhydroquinone. Contact Dermatitis. 2020;83(2):132-4. doi:10.1111/cod.13542.
34 Pal B, Kumari S, Kumari A, Singh SK, Babbar H. Allergic contact dermatitis to lip care cosmetic products – a systematic review. Cutan Ocul Toxicol. 2024;43(1):13-21.
35 Holcomb ZE, Van Noord MG, Atwater AR. Gallate Contact Dermatitis: Product Update and Systematic Review. Dermatitis. 2017;28(2):115- 27. doi:10.1097/DER.0000000000000263.
36 O’Gorman SM, Torgerson RR. Contact allergy in cheilitis. Int J Dermatol. 2016;55(7):e386-e391. doi:10.1111/ijd.13044.
37 Ozbagcivan O, Akarsu S, Dolas N, Fetil E. Contact sensitization to cosmetic series of allergens in patients with rosacea: A prospective controlled study. J Cosmet Dermatol. 2020;19(1):173-9. doi:10.1111/ jocd.12989.
38 Whitehouse H, Uter W, Geier J, Ballmer-Weber B, Bauer A, Cooper S, et al. Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers- results of the ESSCA network, 2015-2018. Contact Dermatitis. 2021;84(2):95-102. doi:10.1111/ cod.13691.
39 Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: A clinical review and update. Contact Dermatitis. 2022;87(1):20-7. doi:10.1111/cod.14089.
40 Sanz-Sánchez T, García PM, Silvestre Salvador JF, Mendaza FH, Guijarro SC, Pérez RG, et al. Contact allergy to formaldehyde releasers. Prospective multicenter study. Contact Dermatitis. 2020;82(3):173-5. doi:10.1111/cod.13417.
41 Vanhoutte C, Goossens A, Gilissen L, Huygens S, Vital-Durand D, Dendooven E, et al. Concomitant contact-allergic reactions to iodopropynyl butylcarbamate and iodine. Contact Dermatitis. 2019;81(1):17-23. doi:10.1111/cod.13224.
42 Batista M, Morgado F, Gonçalo M. Patch test reactivity to iodopropynyl butylcarbamate in consecutive patients during a period of 7 years. Contact Dermatitis. 2019;81(1):54-5. doi:10.1111/cod.13213.
43 Mizutani H, Nguyen J, Tam MM, Tate B, Cahill J, Nixon R. Patch test reactivity to iodopropynyl butylcarbamate between 2011 and 2018 in Melbourne , Australia. Contact Dermatitis. 2021;85(5):604-6. doi:10.1111/cod.13930.
44 Kwon HJ, Kim JM, Oh WJ, Park KY, Kim MN, Seo SJ. Allergic contact dermatitis caused by a moisturizer containing iodopropynyl butylcarbamate. Clin Exp Dermatol. 2018;43(1):62-3.
45 Belluco PES, De-Alcântara CTDA, Belluco JEF, Ferreira MD, Belluco RZF, Azevedo F da SM. Dermatite de contato aos alquil glicosídeos: estamos cientes da importância? Arq Asmas Alerg e Imunol. 2024;8(4):371-6. doi:10.5935/2526-5393.20240050.
46 Warshaw EM, Xiong M, Atwater AR, DeKoven JG, Pratt MD, Maibach HI, et al. Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018. J Am Acad Dermatol. 2022;87(5):1033-41. doi:10.1016/j.jaad.2022.04.058.
47 Warshaw EM, Xiong M, DeKoven JG, Taylor JS, Belsito D V, Reeder MJ, et al. Co-reactivity of glucosides: Retrospective analysis of North American Contact Dermatitis Group Data 2019–2020. Contact Dermatitis. 2023;88(2):153-6. doi:10.1111/cod.14237.
48 Soriano LF, Bertram CG, Chowdhury MMU, Cousen P, Divekar P, Ghaffar SA, et al. Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland. Br J Dermatol. 2021;184(3):571-3. doi:10.1111/bjd.19603.
49 Severin RK, Belsito DV. Patch Testing with Decyl and Lauryl Glucoside: How Well Does One Screen for Contact Allergic Reactions to the Other? Dermatitis. 2017;28(6):342-5. doi:10.1097/ DER.0000000000000327.
50 Alfalah M, Loranger C, Sasseville D. Alkyl Glucosides. Dermatitis. 2017;28(1):3-4. doi:10.1097/DER.0000000000000234.
51 Martínez-González MI, González-Pérez R, García-Rio I, HerasGonzález S. Allergic contact dermatitis caused by benzoic acid and lauryl glucoside in a sunscreen. Contact Dermatitis. 2017;77(3):186-7. doi:10.1111/cod.12810.
52 de Groot A, Schmidt E. Essential Oils, Part V: Peppermint Oil, Lavender Oil, and Lemongrass Oil. Dermatitis. 2016;27(6):325-32. doi:10.1097/DER.0000000000000218.
53 Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV, et al. Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009–2020). Dermatitis. 2024:1-7. doi:10.1089/derm.2024.0118.
54 Griggs J, Almohanna H, Ahmed A, Ren S, Tosti A. “Fresh Breath” on Toothpaste: Peppermint as Cause of Cheilitis. Dermatitis. 2019;30(1):74-5. doi:10.1097/DER.0000000000000433.
55 Bourgeois P, Goossens A. Allergic contact cheilitis caused by menthol in toothpaste and throat medication: a case report. Contact Dermatitis. 2016;75(2):113-5. doi:10.1111/cod.12571.
56 Schubert S, Worm M, Dickel H, Wagner N, Brans R, Schröder-Kraft C, et al. Patch testing shellac in consecutive patients-Data of the Information Network of Departments of Dermatology (IVDK) 2021. Contact Dermatitis. 2023;88(1):77-80. doi:10.1111/cod.14227.
57 Mercader-García P, Ruiz-Gonzalez I, Gonzalez-Perez R, SanzSanchez T, Sanchez-Pérez J, Borrego L. Alergia de contacto a shellac. Estudio transversal retrospectivo con datos del Registro Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (REIDAC). Actas Dermosifiliogr. 2023;114(5):T377-T381. doi:10.1016/j.ad.2023.04.010.
58 Veverka KK, Killian JM, Yiannias JA, Hall MR, Drage LA, Davis MDP. Shellac: A Tertiary Care Center Experience. Dermatitis. 2018;29(4):226-7. doi:10.1097/DER.0000000000000394.
59 Mercader-García P, Ruiz-Gonzalez I, Gonzalez-Perez R, SanzSanchez T, Sanchez-Pérez J, Borrego L. Contact Allergy to Shellac. Retrospective Cross-Sectional Study With Data From the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC). Actas Dermosifiliogr. 2023;114(5):377-81.
60 Warshaw EM, Voller LM, Maibach HI, Zug KA, DeKoven JG, Atwater AR, et al. Eyelid dermatitis in patients referred for patch testing: Retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. J Am Acad Dermatol. 2021;84(4):953-64. doi:10.1016/j.jaad.2020.07.020.
61 Navarro-Triviño FJ. Allergic contact dermatitis from shellac in an ecological hair spray occurring in a patient with frontal fibrosing alopecia. Contact Dermatitis. 2022;86(6):544-5.
62 Warshaw EM, Ruggiero JL, DeKoven JG, Silverberg JI, Maibach HI, Taylor JS, et al. Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 2016. Dermatitis. 2021;32(5):308-18.
63 Chen R, Raffi J, Murase JE. Tocopherol Allergic Dermatitis Masquerading as Lifelong Atopic Dermatitis. Dermatitis. 2020;31(1):e3-e4. doi:10.1097/DER.0000000000000543.
64 Teo CWL, Tay SHY, Tey HL, Ung YW, Yap WN. Vitamin E in Atopic Dermatitis: From Preclinical to Clinical Studies. Dermatology. 2021;237(4):553-64. doi:10.1159/000510653.
65 Schalock PC, Dunnick CA, Nedorost S, Brod B, Warshaw E, Mowad C. American Contact Dermatitis Society Core Allergen Series: 2017 Update. Dermatitis. 2017;28(2):141-3. doi:10.1097/ DER.0000000000000261.
66 Aerts O, Goossens A. Contact Allergy to Preservatives. In: Contact Dermatitis. Springer International Publishing; 2021:835-76. doi:10.1007/978-3-030-36335-2_85.
67 Dear K, Palmer A, Nixon R. Contact allergy and allergic contact dermatitis from benzalkonium chloride in a tertiary dermatology center in Melbourne, Australia. Contact Dermatitis. 2021;85(2):146- 53. doi:10.1111/cod.13826.
68 Okeke CAV, Khanna R, Ehrlich A. Quaternary Ammonium Compounds and Contact Dermatitis: A Review and Considerations During the COVID-19 Pandemic. Clin Cosmet Investig Dermatol. 2023;Volume 16(June):1721-8. doi:10.2147/CCID.S410910.
69 Weinhammer AP, Scheman A, Reeder MJ. Prevalence of Surfactant in the Contact Allergen Management Program. Dermatitis. 2019;30(6):358-62. doi:10.1097/DER.0000000000000511.
70 Chen J, Yin M, Wu R, Dou X. Allergic contact dermatitis caused by benzalkonium chloride from laundry disinfectant. Int J Dermatol. 2024;63(1):119-20. doi:10.1111/ijd.16909.
71 Armengot-Carbo MAC, Rodríguez-Serna M, Taberner-Bonastre P, Miquel-Miquel J. Allergic contact dermatitis from cetearyl alcohol in Thrombocid® ointment. Dermatol Online J. 2016;22(7). doi:10.5070/ D3227031656.
72 Aschenbeck KA, Warshaw EM. Allergenic Ingredients in Facial Wet Wipes. Dermatitis. 2017;28(6):353-9. doi:10.1097/ DER.0000000000000268.
73 Hiranput S, McAllister L, Hill G, Yesudian PD. Do hypoallergenic skincare products contain fewer potential contact allergens? Clin Exp Dermatol. 2024;49(4):386-7. doi:10.1093/ced/llad436.
74 Erfurt-Berge C, Geier J, Mahler V. The current spectrum of contact sensitization in patients with chronic leg ulcers or stasis dermatitis – new data from the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis. 2017;77(3):151-8.
Submetido em:
01/07/2025
Aceito em:
26/10/2025
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email